PCVX (STOCKS)
Vaxcyte, Inc. Common Stock
$49.560000
+2.100000 (+4.42%)
Prev close: $47.460000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Grant E. Pickering
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $7,156.36M
- Employees
- 414
- P/E (TTM)
- -7.11
- P/B (TTM)
- 2.39
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-2.30 | $-1.79 | -0.5135 | -28.74% |
|
Dec 2025 (Q4)
|
$-1.80 | $-1.55 | -0.2541 | -16.44% |
|
Sep 2025 (Q3)
|
$-1.56 | $-1.29 | -0.2657 | -20.53% |
|
Jun 2025 (Q2)
|
$-1.22 | $-1.19 | -0.0251 | -2.10% |
Financial Statements
| Assets | $3.35B |
| Current Assets | $1.81B |
| Noncurrent Assets | $1.53B |
| Fixed Assets | $260.70M |
| Other Non-current Assets | $1.27B |
| Liabilities | $352.29M |
| Current Liabilities | $242.08M |
| Accounts Payable | $63.06M |
| Wages | $7.99M |
| Other Current Liabilities | $171.04M |
| Noncurrent Liabilities | $110.21M |
| Equity | $3.00B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.00B |
| Liabilities And Equity | $3.35B |